In a retrospective study between 2018 and 2020 on 248 patients, Zhao et al. revealed that the CRP/serum albumin ratio is a promising, noninvasive prognostic indicator for patients with AP, capable of predicting SAP, mortality, pancreatic necrosis, and organ failure [58]. This evidence concerns the gene CRP and alkaline phosphatase measurement.